AC-03-20-2026: Fiscal Year (FY) 2026 AmeriCorps State and National Native Nations Grants
Closed
This grant is closed. A newer notice from the same program is open now: Fiscal Year (FY) 2027 AmeriCorps State and National Competitive Grants (AC-08-28-26). Status: Closes January 13, 2027 (67 days left). It is in our archive of AmeriCorps notices from 2026.
AmeriCorps offered grants to tribes. Applications closed on May 20, 2026.
From the official notice on Grants.gov, last changed March 20, 2026. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | March 20, 2026 |
|---|---|
| Deadline | May 20, 2026 |
| Archived by Grants.gov | May 21, 2026 |
Who can apply
This opportunity was open to tribes.
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
n/a
Is this a realistic fit?
- Most of the program's money (74% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
AmeriCorps improves lives, strengthens communities, and fosters civic engagement through service and volunteering. AmeriCorps brings people together to tackle some of the country’s most pressing challenges through national service and volunteerism. AmeriCorps members serve with organizations dedicated to the improvement of communities and those serving. AmeriCorps grants are awarded to eligible organizations engaging AmeriCorps members in evidence-based or evidence-informed interventions to strengthen communities. An AmeriCorps member is person who does community service through AmeriCorps. Members may receive a living allowance and other benefits. After successful completion of their service, members earn a Segal AmeriCorps Education Award they can use to pay for higher education expenses or apply to qualified student loans.
Who has won AmeriCorps State and National 94.006 grants before
From fiscal 2021 to 2025, AmeriCorps State and National 94.006 (94.006) awarded $2.8 billion across 614 grant awards, an average of $4.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Serveminnesota | Minnesota | 7 | $238 million |
| Governors Office of Planning & Research | California | 7 | $161 million |
| The Onestar National Service Commission, Inc. | Texas | 10 | $141 million |
| New York State Commission on National & Community Service | New York | 9 | $96.8 million |
| Governor Office of Service & Community Engagement | California | 5 | $93.7 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, AC-08-28-26, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is AC-03-20-2026 still open?
No. It closed on May 20, 2026. A newer notice is open: AC-08-28-26, closes January 13, 2027 (67 days left).
Who can apply for Fiscal Year (FY) 2026 AmeriCorps State and National Native Nations Grants?
AmeriCorps accepted applications from tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Fiscal Year (FY) 2026 AmeriCorps State and National Native Nations Grants?
Closed May 20, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won AmeriCorps State and National 94.006 grants before?
The largest recipients over five fiscal years were Serveminnesota, Governors Office of Planning & Research, The Onestar National Service Commission, Inc. The program made 614 awards worth $2.8 billion in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)